What is the recommended first-line treatment for acute pericarditis?

Treatment for Acute Pericarditis

The first-line treatment for acute pericarditis is combination therapy with aspirin or NSAIDs plus colchicine for 3 months, with gastroprotection. 1

First-Line Therapy (Class I, Level A Recommendation)

The 2015 ESC Guidelines provide clear, evidence-based recommendations for initial management:

Anti-Inflammatory Therapy

• Aspirin: 750-1000 mg every 8 hours for 1-2 weeks 1
• OR Ibuprofen: 600 mg every 8 hours for 1-2 weeks 1
• Always provide gastroprotection (proton pump inhibitor)

Add Colchicine (Mandatory)

• Weight-adjusted dosing 1:
  • <70 kg: 0.5 mg once daily
  • ≥70 kg: 0.5 mg twice daily
• Duration: 3 months (not optional—this halves the recurrence rate from 30% to 15%) 1

Treatment Duration and Tapering

• Continue NSAIDs/aspirin until symptoms resolve AND C-reactive protein (CRP) normalizes (typically 1-2 weeks) 1
• Taper aspirin by 250-500 mg every 1-2 weeks 1
• Taper ibuprofen by 200-400 mg every 1-2 weeks 1
• Colchicine tapering is not mandatory but can be done in final weeks 1

Critical Monitoring

• Use CRP to guide treatment duration—do not taper until CRP normalizes 1
• Each tapering attempt should only occur when patient is asymptomatic AND CRP is normal 1

Exercise Restriction

• Non-athletes: Restrict exercise until symptoms resolve and CRP, ECG, and echocardiogram normalize 1
• Athletes: Minimum 3-month restriction from competitive sports after symptom onset 1

Second-Line Therapy (When First-Line Fails or Contraindicated)

Low-dose corticosteroids should be considered only when 1:

• True contraindication to NSAIDs/colchicine exists (allergy, recent GI bleeding, high bleeding risk on anticoagulation)
• Specific indication present (autoimmune disease, pregnancy >20 weeks, post-pericardiotomy syndrome)
• Infectious cause has been excluded (especially bacterial and TB)

Dosing if used: Prednisone 0.2-0.5 mg/kg/day (NOT 1.0 mg/kg/day) 1

Critical Pitfall: Avoid Corticosteroids as First-Line

Corticosteroids are NOT recommended as first-line therapy (Class III recommendation) 1. They:

• Favor chronicity and recurrence
• Increase recurrence risk to 50% after first episode 1
• Promote drug dependence
• Should be added TO (not replace) NSAIDs/colchicine if needed 1

Why This Combination Works

The evidence is compelling: 15-30% of patients develop recurrent pericarditis without colchicine, but colchicine halves this rate 1. The combination of NSAIDs (for acute inflammation control) plus colchicine (for recurrence prevention) addresses both immediate symptoms and long-term outcomes—directly impacting quality of life by preventing the debilitating cycle of recurrent disease.

Practical Algorithm

1. Confirm diagnosis (≥2 of: pleuritic chest pain, friction rub, ECG changes, pericardial effusion)
2. Exclude high-risk features requiring admission (fever >38°C, large effusion, tamponade, immunosuppression, trauma, anticoagulation failure)
3. Start combination therapy immediately:
   • Ibuprofen 600 mg TID OR aspirin 750-1000 mg TID
   • PLUS colchicine (weight-adjusted)
   • PLUS PPI
4. Monitor CRP at baseline and during treatment
5. Taper NSAIDs/aspirin only after symptoms resolve AND CRP normalizes
6. Continue colchicine for full 3 months
7. Restrict exercise appropriately

Recent research confirms IL-1 inhibitors (anakinra, rilonacept) are transforming management of recurrent/refractory cases 2, 3, 4, but these are reserved for patients who fail first-line therapy or develop corticosteroid dependence 1, 5.